CA3054284C - Méthodes de traitement de la fibrose par ciblage de smoc2 - Google Patents

Méthodes de traitement de la fibrose par ciblage de smoc2

Info

Publication number
CA3054284C
CA3054284C CA3054284A CA3054284A CA3054284C CA 3054284 C CA3054284 C CA 3054284C CA 3054284 A CA3054284 A CA 3054284A CA 3054284 A CA3054284 A CA 3054284A CA 3054284 C CA3054284 C CA 3054284C
Authority
CA
Canada
Prior art keywords
smoc2
inhibitor
fibrosis
nucleic acid
kidney
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3054284A
Other languages
English (en)
Other versions
CA3054284A1 (fr
Inventor
Vishal S. Vaidya
Casimiro Gerarduzzi
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Priority claimed from PCT/US2017/018753 external-priority patent/WO2017147087A1/fr
Publication of CA3054284A1 publication Critical patent/CA3054284A1/fr
Application granted granted Critical
Publication of CA3054284C publication Critical patent/CA3054284C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Il est décrit des méthodes de traitement d’une fibrose, par exemple une fibrose rénale, à l’aide d’agents qui ciblent la protéine 2 de liaison au calcium modulaire sécrétée (SMOC2).
CA3054284A 2016-02-25 2017-02-21 Méthodes de traitement de la fibrose par ciblage de smoc2 Active CA3054284C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662299618P 2016-02-25 2016-02-25
US62/299,618 2016-02-25
PCT/US2017/018753 WO2017147087A1 (fr) 2016-02-25 2017-02-21 Méthodes de traitement de la fibrose par ciblage de smoc2

Publications (2)

Publication Number Publication Date
CA3054284A1 CA3054284A1 (fr) 2017-08-31
CA3054284C true CA3054284C (fr) 2025-07-08

Family

ID=

Similar Documents

Publication Publication Date Title
US20250186480A1 (en) Treatment Methods for Fibrosis Targeting SMOC2
US20180155414A1 (en) Targeting Apolipoprotein E (APOE) in Neurologic Disease
US9322015B2 (en) Methods of using microRNA-26a to promote angiogenesis
US9789132B2 (en) Methods targeting miR-128 for regulating cholesterol/lipid metabolism
WO2021231678A1 (fr) Réduction de la résistance à médiation par prominine 2 à la mort cellulaire ferroptotique
US20230287427A1 (en) Inhibition of lncExACT1 to Treat Heart Disease
CN104995300B (zh) Rna活性和血管通透性的调节
US10260067B2 (en) Enhancing dermal wound healing by downregulating microRNA-26a
US20220340908A1 (en) Methods for depletion of deleterious mitochondrial genomes
HK40122379A (en) Treatment methods for fibrosis targeting smoc2
HK40002857A (en) Treatment methods for fibrosis targeting smoc2
HK40002857B (en) Treatment methods for fibrosis targeting smoc2
US11512316B2 (en) Enhanced organogenesis through manipulation of LIN28/LET-7/DIS3L2
AU2021228769A1 (en) Usp10 targeted self-deliverable siRNA compositions and methods for preventing or inhibiting fibrosis and/or scarring
US20220340903A1 (en) Targeting rlim to modulate body weight and obesity